HOME >> BIOLOGY >> NEWS
New observational study suggests use of combination vaccines may improve immunization coverage rates in infants

Atlanta, GA (March 8, 2006) V Results from a new observational study of administrative claims data from the Georgia State Medicaid program showed that infants who received a combination vaccine had higher immunization coverage rates in the first two years of life compared to infants given component vaccines. Results from the study were presented today at the Centers for Disease Control and Prevention's 40th National Immunization Conference (NIC) in Atlanta, GA, by Gary S. Marshall, M.D., Professor of Pediatrics at University of Louisville, Louisville, KY. The study was conducted by Dr. Marshall in collaboration with Applied Health Outcomes of Palm Harbor, Florida.

The study evaluated the immunization history of infants born between January and September 2003, with continuous enrollment in the Georgia Medicaid Program for at least 24 months following birth, identified from administrative claims of the Georgia Department of Community Health. Infants who were eligible for the study were distributed into two cohorts. The combination group (N=1990) was made up of those infants who received at least one dose of PEDIARIX [Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed (DTaP), Hepatitis B (Recombinant, HepB) and Inactivated Poliovirus Vaccine (IPV) Combined] and the component group (N=1990) consisted of those who were immunized with separate injections of DTaP, HepB and IPV or alternate combinations (DTaP-Hib or HepB-Hib)]. Each infant in the combination vaccine group was matched by gender and birth date to an infant in the component vaccine group. Immunization coverage rates were evaluated at 24 months of age by comparing the status of actual vaccinations administered according to the ACIP/AAP/AAFP recommended immunization schedule.

Results from the analysis showed that the combination cohort had significantly higher coverage rates than the component cohort for 4 doses of diphtheria, tetanus and pertussis (DTaP) vaccine (58.0 percen
'"/>


8-Mar-2006


Page: 1 2 3 4

Related biology news :

1. New study warns limited carbon market puts 20 percent of tropical forest at risk
2. Clones on task serve greater good, evolutionary study shows
3. Pollution causes 40 percent of deaths worldwide, study finds
4. A study by the MUHC and McGill University opens a new door to understanding cancer
5. New study suggests Concord grape juice may provide protection against breast cancer
6. Preclinical study links gene to brain aneurysm formation
7. In limiting life span, study finds booming bacteria innocent
8. Multicenter study nets new lung tumor-suppressor gene
9. MIT study: Maturity brings richer memories
10. Chickadee, nutchatch presence in conifers increases tree growth, says CU-Boulder study
11. Phase II study of therapeutic vaccine shows efficacy in patients with metastatic colorectal cancer

Post Your Comments:
(Date:5/17/2013)... The Federation of American Societies for Experimental Biology ... Institutes of Health (NIH) funding trends highlighting the devastating ... critical research. The FASEB analysis follows a May 15th ... MD, PhD, who testified that the $1.6 billion cut ... is "having a substantial impact on the scientific community." ...
(Date:5/16/2013)... living closer to a fast food restaurant had a ... further away from fast food, according to researchers at ... this association was particularly strong among those with a ... in the American Journal of Public Health ... fast food restaurant, and among lower-income African-Americans, the density, ...
(Date:5/16/2013)... relationship between the heritable risk for schizophrenia and ... is commonly associated with cognitive impairments that may ... IQ may be linked to the risk for ... precede the onset of schizophrenia symptoms. Also, these ... people diagnosed with schizophrenia. , In a remarkable ...
Breaking Biology News(10 mins):Body mass index of low income African-Americans linked to proximity of fast food restaurants 2Body mass index of low income African-Americans linked to proximity of fast food restaurants 3Genetic risk for schizophrenia is connected to reduced IQ 2
(Date:5/16/2013)... Kitware , a leading provider ... Phase II SBIR funding from the U.S. Department ... open-source, high performance computing (HPC) simulation and computation ... to select only the toolkits and applications needed ... analysis tasks. , Manufacturers increasingly rely on ...
(Date:5/16/2013)... May 16, 2013 Scientists at the Center ... , and the California -based ... a novel therapy for reversing memory decline in mice ... find significant cognitive improvement in advanced stage AD mice. ... for reversing cognitive decline for advanced stage AD mice, ...
(Date:5/16/2013)... , May 16, 2013 ... research report is available in its ... Competitor Analysis: Therapeutic Proteins – ... http://www.reportlinker.com/p01171947/Competitor-Analysis-Therapeutic-Proteins-–-Biosimilars-Biobetters--Biosuperiors.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biopharmaceutical   ... The new Competitive Intelligence ...
(Date:5/16/2013)... (PRWEB) May 16, 2013 DNA Genotek, a ... ‘Spit for Africa’, a sponsorship program in conjunction with the ... designed to improve access and reduce the cost of ... such as the Human Heredity and Health in Africa (H3 ... AfSHG. , The aim of the AfSHG is ...
Breaking Biology Technology:Kitware Develops a Customizable Simulation Framework to Provide HPC for Small to Mid-Sized Manufacturers 2Elevation of Brain Magnesium Reverses Memory Deficits in Alzheimer Mice 2Elevation of Brain Magnesium Reverses Memory Deficits in Alzheimer Mice 3Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 2Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 3Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 4Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 5Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 6Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 7Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 8DNA Genotek Inc. Announces Spit for Africa Program 2DNA Genotek Inc. Announces Spit for Africa Program 3
Cached News: